common.study.topics.clinical

Reducing Concurrent Opioid-Benzodiazepine Prescriptions

common.study.values.description

Reducing Concurrent Opioid-Benzodiazepine Prescriptions

The purpose of this effort is to use informative e-mails to improve the process of prescribing of opioids and benzodiazepines within the National Capital Region/Military Health System (NCR/MHS), with the aim of decreasing concurrent opioid and benzodiazepine prescribing.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Behavioral - E-mail Alert

Encrypted email to the following providers: the patient's opioid prescriber(s), benzodiazepine prescriber(s), and/or primary care manager. If there is more than one provider, they are copied together on the same message. The email identifies the concurrent prescriptions, details the patient's prescription history, includes relevant VA/DoD guidelines, states the risk of concurrent prescribing to patient, and provides action steps and relevant resources. When multiple providers are involved, the m ...read more on ClinicalTrials.org

participant.views.study.view.additional

participant.views.study.view.scientific-title

Reducing Concurrent Opioid-Benzodiazepine Prescriptions Through Provider Intervention

common.study.values.clinical-trial-id

NCT03887247

participant.views.study.view.id

bqx5ka